The 10th Annual Johns Hopkins Multiple Sclerosis Series- Current and Emerging Treatment Options- Multiple sclerosis (MS) has been long considered an inflammatory and demyelinating disease of the central nervous system. In recent years, our increased understanding of MS pathogenesis and the significance of neurodegenerative process has led to the development of more effective therapies. Although there is no cure for MS, current and emerging targeted treatments aim to slow disease progression, reduce relapses, and limit disability. However, many uncertainties remain in the diagnosis, treatment, and overall management of patients with MS: How to recognize symptoms and accurately diagnose MS? Which diagnostic tests should be performed? Which therapies should be used? When to initiate, switch, and/or discontinue treatment? How to optimally manage symptoms while minimizing treatment side effects and improve patient’s health-related quality of life?
DISCUSS efficacy and safety data of emerging and currently available therapies.
APPLY MS diagnosis and management plans in diverse patients.
1.5 Free CEUs for Nurses
This course also offers Free CME for
Physicians
Expires 5/25/17
Supported by educational grants from Biogen Idec, Questcor, Genzyme, a Sanofi company, Teva Pharmaceuticals, and EMD Sorono, Inc.